The European Commission (EC) has approved a new Opdivo (nivolumab) formulation associated with a new route of administration ...

Bristol Myers Squibb receives European approval for subcutaneous formulation of Opdivo across multiple solid tumour indications: Princeton, New Jersey Thursday, May 29, 2025, 15:0 ...

Viking Therapeutics faces tough obesity drug rivals, with VK2735 showing promise but an uncertain edge. Find out why VKTX ...

Princeton: Bristol Myers Squibb has received approval from the European Commission (EC) for a new Opdivo (nivolumab) ...

Carfilzomib-based induction/consolidation with or without autologous transplant (ASCT) followed by lenalidomide (R) or carfilzomib-lenalidomide (KR) maintenance: Efficacy in high-risk patients. This ...

Prior meta-analyses examined the effects of drug formulation before phase 3 data on racemic ketamine were available, did not examine single versus repeated dosing or route of administration on the ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Interest in developing nasal dosage forms has increased significantly in the last two years, driven by a number of recent ...

Biocon shares rose over 2 per cent after Biocon Biologics' Japanese commercial partner launched Ustekinumab BS Subcutaneous ...

Research agreement is evaluating feasibility of applying Rani’s oral delivery technology to Chugai’s antibodies against ...

For the marathon on Sunday, organizers even have designated a "featured party stop" at Saucy Brew Works, located at Mile 16.3 of the marathon route, where spectators can stop for food and drinks.

The subcutaneous injection is a tyrosine kinase inhibitor designed to block all forms of VEGF, Singer explained at the Retina World Congress. A study investigated migaldendranib (Ashvattha ...